Detalhe da pesquisa
1.
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Blood
; 141(23): 2901-2911, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940410
2.
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
Am J Hematol
; 99(4): 741-744, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279562
3.
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.
Br J Haematol
; 201(2): 234-248, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546586
4.
Dual role of EZH2 in megakaryocyte differentiation.
Blood
; 138(17): 1603-1614, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115825
5.
Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms.
Blood
; 138(22): 2231-2243, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407546
6.
Comprehensive in silico and functional studies for classification of EPAS1/HIF2A genetic variants identified in patients with erythrocytosis.
Haematologica
; 108(6): 1652-1666, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700397
7.
Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.
Haematologica
; 108(11): 3068-3085, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317877
8.
Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies.
Am J Hematol
; 98(5): 794-800, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869873
9.
Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
Br J Haematol
; 196(3): 676-680, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562020
10.
Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations.
Blood
; 135(13): 1032-1043, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961934
11.
MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491.
Blood
; 135(12): 948-953, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978223
12.
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation.
Blood
; 133(20): 2233-2242, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760453
13.
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.
Blood
; 133(16): 1766-1777, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755419
14.
ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis.
Int J Mol Sci
; 22(7)2021 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33805426
15.
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?
Biol Blood Marrow Transplant
; 26(6): 1160-1170, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119970
16.
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.
Haematologica
; 105(6): 1539-1551, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488557
17.
Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls.
Ann Hematol
; 98(1): 111-118, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259120
18.
International external quality assurance of JAK2 V617F quantification.
Ann Hematol
; 98(5): 1111-1118, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535576
19.
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.
Eur J Haematol
; 103(6): 552-557, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446640
20.
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Blood
; 138(21): 2142-2148, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945619